Genital Warts Clinical Trial
Official title:
Prevalence of HPV Genotypes in Genital Warts in Colombian Male and Female Population Attending Medical Services.
HPV infection has been recognized as the most prevalent sexual transmitted infection
worldwide. Burden of many HPV related diseases is well known particularly regarding the
different associated cancers (cervical, anal, vaginal, vulvar, oro-pharyngeal) (3) ; however,
there is much less available information on the general burden of genital warts, the
associated HPV types, the costs of related medical treatments and the knowledge and
perceptions towards the disease and its prevention.
Objectives:
1. To determine the HPV genotypes distribution in genital warts in the study population.
2. To assess the knowledge about transmission & prevention of HPV infection related
diseases
3. To determine the direct medical costs of genital warts attention.
Study population
Female and male between 18 - 45 years of age living in Bogota, Colombia
Sample frame
Patients attending to gynecologic or STD consult in a mayor out patient clinic in Bogotá
(PROFAMILIA)
Analysis
Analysis of the information will be exhaustive. We will calculate prevalence of HPV genotypes
in the GW in both sexes separately. Analyses of the survey will include simple frequencies,
percentages, and comparison of results related to HPV knowledge with sociodemographic and
clinical information. Explorative analysis using parametric or non parametric statistics of
the items included in the questionnaire and clinical forms will be done as appropriate. We
will calculate the medical cost of patients enrolled in the study. The treatment protocols
used for this protocol will reflect the current clinical practice accepted for the treatment
of genital warts. We will use national reference cost list (SOAT) to determine the cost of
procedures included.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
| Completed |
NCT03158220 -
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
|
Phase 3 | |
| Completed |
NCT01651949 -
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)
|
Phase 3 | |
| Completed |
NCT00551187 -
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
|
Phase 2 | |
| Completed |
NCT00520598 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
|
Phase 2 | |
| Terminated |
NCT01468636 -
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
|
Phase 4 | |
| Recruiting |
NCT03296397 -
Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response
|
Phase 3 | |
| Active, not recruiting |
NCT05314023 -
Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)
|
Phase 3 | |
| Completed |
NCT00674739 -
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
|
Phase 3 | |
| Recruiting |
NCT03948321 -
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts
|
N/A | |
| Completed |
NCT00862810 -
Alternate Dosing Schedules Study for HPV Vaccine
|
Phase 4 | |
| Completed |
NCT02280642 -
Alternate Dosing Schedules Study for HPV Vaccine (ADS)
|
Phase 4 | |
| Completed |
NCT00092482 -
Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)
|
Phase 3 | |
| Completed |
NCT02188004 -
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
|
||
| Completed |
NCT01553994 -
Effectiveness Study of Gardasil on Condyloma
|
N/A | |
| Completed |
NCT00189293 -
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
|
Phase 4 | |
| Active, not recruiting |
NCT00092534 -
Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)
|
Phase 3 | |
| Completed |
NCT02462187 -
Topical NVN1000 for the Treatment of External Genital and Perianal Warts
|
Phase 2 | |
| Completed |
NCT00501137 -
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
|
Phase 3 | |
| Active, not recruiting |
NCT02750202 -
Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
|
Phase 3 |